209 related articles for article (PubMed ID: 20842591)
41. Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide.
Kong DS; Kim HR; Choi YR; Seol HJ; Lee JI; Nam DH
J Clin Neurosci; 2015 Sep; 22(9):1425-9. PubMed ID: 26138051
[TBL] [Abstract][Full Text] [Related]
42. Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma.
Landy H; Markoe A; Potter P; Lasalle G; Marini A; Savaraj N; Reis I; Heros D; Wangpaichitr M; Feun L
J Neurooncol; 2004; 67(1-2):215-20. PubMed ID: 15072470
[TBL] [Abstract][Full Text] [Related]
43. [Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts].
Wick W; Weller M
Nervenarzt; 2010 Aug; 81(8):928-30, 932-5. PubMed ID: 20635074
[TBL] [Abstract][Full Text] [Related]
44. Recent developments in the molecular characterization and treatment of oligodendroglial tumors.
van den Bent M; Chinot OL; Cairncross JG
Neuro Oncol; 2003 Apr; 5(2):128-38. PubMed ID: 12672285
[TBL] [Abstract][Full Text] [Related]
45. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
46. State-of-the-art treatment of high-grade brain tumors.
Brandes AA
Semin Oncol; 2003 Dec; 30(6 Suppl 19):4-9. PubMed ID: 14765377
[TBL] [Abstract][Full Text] [Related]
47. Management of diffusely infiltrating glioma in the elderly.
Wirsching HG; Happold C; Roth P; Weller M
Curr Opin Oncol; 2015 Nov; 27(6):502-9. PubMed ID: 26397765
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant chemotherapy for adults with malignant glioma: a systematic review.
Perry J; Laperriere N; Zuraw L; Chambers A; Spithoff K; Cairncross JG; ;
Can J Neurol Sci; 2007 Nov; 34(4):402-10. PubMed ID: 18062446
[TBL] [Abstract][Full Text] [Related]
49. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
Kim YH; Park CK; Cho WH; Kim IA; Moon S; Choe G; Park SH; Kim IH; Kim DG; Jung HW; Lee MM; Bae SH; Cha SH; Kim CY
J Neurooncol; 2011 Jul; 103(3):503-12. PubMed ID: 20862518
[TBL] [Abstract][Full Text] [Related]
50. Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
Bergman D; Modh A; Schultz L; Snyder J; Mikkelsen T; Shah M; Ryu S; Siddiqui MS; Walbert T
J Neurooncol; 2020 Jun; 148(2):353-361. PubMed ID: 32444980
[TBL] [Abstract][Full Text] [Related]
51. Evidence-Based Practice: Temozolomide Beyond Glioblastoma.
Chua J; Nafziger E; Leung D
Curr Oncol Rep; 2019 Mar; 21(4):30. PubMed ID: 30835007
[TBL] [Abstract][Full Text] [Related]
52. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma.
Fujimaki T; Ishii H; Matsuno A; Arai H; Nakagomi T
World J Surg Oncol; 2007 Aug; 5():89. PubMed ID: 17683572
[TBL] [Abstract][Full Text] [Related]
54. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
Wirsching HG; Weller M
Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
[TBL] [Abstract][Full Text] [Related]
55. Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.
Khan MK; Hunter GK; Vogelbaum M; Suh JH; Chao ST
Indian J Cancer; 2009; 46(2):96-107. PubMed ID: 19346643
[TBL] [Abstract][Full Text] [Related]
56. Glioma therapy in adults.
Norden AD; Wen PY
Neurologist; 2006 Nov; 12(6):279-92. PubMed ID: 17122724
[TBL] [Abstract][Full Text] [Related]
57. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
van den Bent MJ; Smits M; Kros JM; Chang SM
J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
[TBL] [Abstract][Full Text] [Related]
58. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
59. Anaplastic gliomas in adults: an update.
Izquierdo C; Joubert B; Ducray F
Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
[TBL] [Abstract][Full Text] [Related]
60. Recent developments in the use of chemotherapy in brain tumours.
van den Bent MJ; Hegi ME; Stupp R
Eur J Cancer; 2006 Mar; 42(5):582-8. PubMed ID: 16427778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
